PRFX (PainReform) Rega marang bathi mangsa ngarep
A stable staff of pharmaceutical scientists ensures the successful completion of Phase 3 trials for PRF-110 and the submission of the FDA application for PainReform Ltd. (PRFX). The company's expected P/E metric reflects the asset's value dynamics, where the parameter mark equals 0.00. Management is implementing a budget-conscious approach to development, aiming to confirm the efficacy of its pain management systems.
Ringkesan rincian data analitis PainReform Corp (PRFX)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal PainReform Ltd.|PRFX - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas PainReform Ltd.|PRFX - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku PainReform Ltd|PRFX - Kewajiban jangka dawa|Utang jangka cendhak perusahaan PainReform|Rasio cepet painreform.com
- rincian asil keuangan lan kelipatan valuasi:
PRFX - Asil keuangan resik|Bathi sing dikarepake PainReform Ltd.|PRFX - Pangali rega marang bathi|Rega marang bathi mangsa ngarep PainReform Limited|PRFX - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA PainReform Ltd|PRFX - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) PainReform|PRFX - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan painreform.com|PRFX - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep PainReform Ltd.
Pambiji fundamental:PRFX PainReform
Forward P/E measures the market value of a business relative to projected net income, allowing investors to assess the premium paid for future earnings while accounting for technological risks. By analyzing the future price-to-earnings ratio of PainReform Ltd. (PRFX), one can see how the market discounts the company's potential to protect margins through unique patents for extended-release analgesics, thereby bypassing mass price competition.
Analisis pesaing PainReform Ltd.
Prakiraan rega marang bathi HLN (Haleon)|KVUE (Kenvue Inc) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Verona Pharma Corp VRNA|Jyong Bio (MENS) - Rasio prakiraan rega marang bathi|LGND: Prakiraan rega marang bathi|amneal.com - Rasio kapitalisasi marang bathi mangsa ngarep|PRGO: Pangali Forward P/E|Alvotech S.A. - Pangali mangsa ngarep rega marang bathi|LQDA (Liquidia Technologies) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Galapagos Corp GLPG|Rega marang bathi mangsa ngarep ANI Pharmaceuticals (ANIP)|MNKD (mannkindcorp.com) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Amphastar Pharmaceuticals, Inc. AMPH|PCRX (Pacira Pharmaceuticals) - Rasio rega marang bathi sing dikarepake|ARS Pharma - Pangali Forward P/E|TBPH - Pangali Forward P/E|AQST: Pangali Forward P/E|SCPH - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Tectonic Therapeutic Inc.|Rasio rega marang bathi mangsa ngarep TNXP (Tonix Pharma)|Rega marang bathi mangsa ngarep China SXT Pharmaceuticals (SXTC)|EPRX (eupraxiapharma.com) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E BHST (BioHarvest Sciences)|invizyne.com (EXOZ) - Rasio prakiraan rega marang bathi|Oramed Pharma - Pangali Forward P/E|Rasio rega marang bathi sing dikarepake ENTX|MindWalk (HYFT) - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi ABVC BioPharma, Inc (ABVC)|Rega marang bathi mangsa ngarep Cumberland Pharmaceuticals|QNTM: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep FibroGen (FGEN)|Prakiraan rega marang bathi Telomir Pharmaceuticals Inc TELO|Rani Therapeutics Holdings, Inc. - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi SNYR|RLYB - Rega marang bathi mangsa ngarep|LEXX: Rega marang bathi mangsa ngarep|PULM (Pulmatrix) - Prakiraan rega marang bathi|PTHL: Rasio kapitalisasi marang bathi mangsa ngarep|APM (Aptorum Group Ltd) - Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep LYRA (Lyra Therapeutics Inc)|Prakiraan rega marang bathi IBO (Impact BioMedical Inc)|Kapitalisasi marang proyeksi bathi tnfpharma.com|Rega marang bathi mangsa ngarep cbdMD YCBD|CYTO (Altamira Therapeutics Ltd) - Rasio rega marang bathi sing dikarepake|LIPO - Rega marang bathi mangsa ngarep|Pangali mangsa ngarep rega marang bathi OPTN (OptiNose Corp)|PIRS: Pangali Forward P/E|Rasio rega marang bathi sing dikarepake PROC (procapsgroup.com)|Prakiraan rega marang bathi PTPI|Rasio rega marang bathi mangsa ngarep QLI (Qilian International Holding Group)|Rega marang bathi mangsa ngarep ACELYRIN, Inc. (SLRN)|TFFP: Rasio rega marang bathi sing dikarepake
